Outcomes and Incidence of PF-ILD According to Different Definitions in a Real-World Setting

• Ngā kaituhi matua: Sebastiano Emanuele Torrisi (Author), Nicolas Kahn (Author), Julia Wälscher (Author), Markus Polke (Author), Joyce S. Lee (Author), Philip L. Molyneaux (Author), Francesca Maria Sambataro (Author), Claus Peter Heussel (Author), Carlo Vancheri (Author), Michael Kreuter (Author)
• Hōputu: Pukapuka
• I whakaputaina: Frontiers Media S.A., 2021-12-01T00:00:00Z.
• Ngā marau: article
• Urunga tuihono: Connect to this object online.

Background: Almost one-third of fibrosing ILD (fILDs) have a clinical disease behavior similar to IPF, demonstrating a progressive phenotype (PF-ILD). However, there are no globally accepted criteria on the definition of a progressive phenotype in non-IPF fILD yet. Four different definitions have be...